|
US2802005A
(en)
|
|
1957-08-06 |
|
S-eluorourace |
|
US2512572A
(en)
|
|
1950-06-20 |
|
Substituted pteridines and method |
|
US1973A
(en)
|
|
1841-02-10 |
|
Method oe cowstettctiitg clocks |
|
US2917432A
(en)
|
1954-10-05 |
1959-12-15 |
Burroughs Wellcome Co |
Leukemia treatment
|
|
US2848455A
(en)
|
1955-07-18 |
1958-08-19 |
Ciba Pharm Prod Inc |
Alpha-(p-amino-phenyl)-alpha-lower alkyl glutarimides
|
|
US2891079A
(en)
|
1959-01-23 |
1959-06-16 |
Searle & Co |
6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof
|
|
US3046301A
(en)
|
1959-10-29 |
1962-07-24 |
Burroughs Wellcome Co |
Method of making chlorambucil
|
|
US3116282A
(en)
|
1960-04-27 |
1963-12-31 |
Upjohn Co |
Pyrimidine nucleosides and process
|
|
BE637389A
(https=)
|
1962-09-13 |
|
|
|
|
US3432549A
(en)
|
1965-04-22 |
1969-03-11 |
Egyt Gyogyszervegyeszeti Gyar |
Pharmacologically active new substituted benzamides
|
|
US3732340A
(en)
|
1966-07-11 |
1973-05-08 |
Asta Werke Ag Chem Fab |
N',o-propylene phosphoric acid ester diamides
|
|
US3803124A
(en)
|
1968-04-12 |
1974-04-09 |
Farmaceutici It Soc |
Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
|
|
CH527207A
(de)
|
1968-05-08 |
1972-08-31 |
Ceskoslovenska Akademie Ved |
Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
|
|
GB1235022A
(en)
|
1969-06-04 |
1971-06-09 |
Laeaeke Ag |
A new method for the production of cyclophosphamide
|
|
CH526500A
(de)
|
1969-12-31 |
1972-08-15 |
Hoffmann La Roche |
Verfahren zur Herstellung von Polyenverbindungen
|
|
DE2124023C3
(de)
|
1970-05-27 |
1980-07-10 |
Richter Gedeon Vegyeszeti Gyar R.T., Budapest |
Verfahren zur selektiven Gewinnung von Vinblastin, Vinleurosin und Vincristin oder von deren Sulfaten
|
|
GB1354939A
(en)
|
1971-10-28 |
1974-06-05 |
Ici Ltd |
Process for the manufacture of 1,1,2-triphenylalk-1-enes
|
|
JPS4910506A
(https=)
|
1972-05-31 |
1974-01-30 |
|
|
|
CH605550A5
(https=)
|
1972-06-08 |
1978-09-29 |
Research Corp |
|
|
AR204004A1
(es)
|
1973-04-02 |
1975-11-12 |
Lilly Co Eli |
Procedimientos para preparar derivados de vinblastina leurosidina y leurocristina
|
|
US4005063A
(en)
|
1973-10-11 |
1977-01-25 |
Abbott Laboratories |
[Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
|
|
US3914412A
(en)
|
1973-10-11 |
1975-10-21 |
Abbott Lab |
{8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
|
|
GB1457632A
(en)
|
1974-03-22 |
1976-12-08 |
Farmaceutici Italia |
Adriamycins
|
|
US4020270A
(en)
|
1974-05-02 |
1977-04-26 |
Societa' Farmaceutici Italia S.P.A. |
L-lyxohex-1-enopyranose derivative
|
|
GB1467383A
(en)
|
1974-06-12 |
1977-03-16 |
Farmaceutici Italia |
Daunomycin analogues
|
|
DE2438350C3
(de)
|
1974-08-09 |
1979-06-13 |
Hoechst Ag, 6000 Frankfurt |
Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4197249A
(en)
|
1977-08-15 |
1980-04-08 |
American Cyanamid Company |
1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
|
|
US4307100A
(en)
|
1978-08-24 |
1981-12-22 |
Agence Nationale De Valorisation De La Recherche (Anvar) |
Nor bis-indole compounds usable as medicaments
|
|
DE2845574A1
(de)
|
1978-10-19 |
1980-04-24 |
Deutsches Krebsforsch |
Durch heterocyclische ringe oder alkylreste substituierte analoga von ccnu und verfahren zu deren herstellung
|
|
DE3046719C2
(de)
|
1980-12-11 |
1983-02-17 |
Klinge Pharma GmbH, 8000 München |
1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
|
|
US4357324A
(en)
|
1981-02-24 |
1982-11-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
OA07174A
(fr)
|
1981-08-24 |
1984-04-30 |
May & Baker Ltd |
Nouvelles imidazotétrazionones, leur préparation et les médicaments qui les contiennent.
|
|
GB2126576B
(en)
|
1982-06-25 |
1985-06-19 |
Farmos Group Limited |
Alkane and alkene derivatives
|
|
EP0100172B1
(en)
|
1982-07-23 |
1987-08-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
|
EP0111058B1
(en)
|
1982-11-26 |
1987-11-04 |
Nippon Kayaku Kabushiki Kaisha |
Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
|
GB8327256D0
(en)
|
1983-10-12 |
1983-11-16 |
Ici Plc |
Steroid derivatives
|
|
US4582909A
(en)
*
|
1984-02-02 |
1986-04-15 |
Warner-Lambert Company |
Benzobicyclic lactam acids and derivatives as cognition activators
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4760064A
(en)
*
|
1984-12-18 |
1988-07-26 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril compounds, compositions containing same and processes for preparing same
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US5003011A
(en)
|
1985-04-09 |
1991-03-26 |
The Administrators Of The Tulane Educational Fund |
Therapeutic decapeptides
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4691918A
(en)
|
1985-10-08 |
1987-09-08 |
Diversified Products Corporation |
Multiple exercise device
|
|
US4978672A
(en)
|
1986-03-07 |
1990-12-18 |
Ciba-Geigy Corporation |
Alpha-heterocyclc substituted tolunitriles
|
|
JPS62220196A
(ja)
|
1986-03-20 |
1987-09-28 |
Kyowa Hakko Kogyo Co Ltd |
新規物質ｕｃｎ―０１
|
|
IN164232B
(https=)
|
1986-04-11 |
1989-02-04 |
Hoechst India |
|
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2601676B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Procede de preparation du taxol et du desacetyl-10 taxol
|
|
NZ224714A
(en)
|
1987-06-01 |
1990-03-27 |
Janssen Pharmaceutica Nv |
Substituted benzotriazole derivatives and pharmaceutical compositions
|
|
GB8714013D0
(en)
|
1987-06-16 |
1987-07-22 |
Ici Plc |
(substituted-aralkyl)heterocyclic compounds
|
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
|
KR0143565B1
(ko)
|
1988-06-13 |
1998-07-15 |
사노 가즈오 |
피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물.
|
|
US4990511A
(en)
|
1988-08-03 |
1991-02-05 |
Takeda Chemical Industries, Ltd. |
Amide compounds, their production and use
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
|
IL96531A
(en)
|
1989-12-11 |
1995-08-31 |
Univ Princeton |
History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
|
|
US5124350A
(en)
*
|
1990-06-28 |
1992-06-23 |
G. D. Searle & Co. |
Leukotriene b4 antagonists
|
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
|
ZA916555B
(en)
|
1990-08-27 |
1993-04-28 |
Lilly Co Eli |
Method of treating inflammatory bowel disease
|
|
TW295589B
(https=)
|
1990-08-30 |
1997-01-11 |
Hoechst Ag |
|
|
FR2669029B1
(fr)
*
|
1990-11-14 |
1994-09-02 |
Adir |
Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
MX9102128A
(es)
|
1990-11-23 |
1992-07-08 |
Rhone Poulenc Rorer Sa |
Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
|
|
US5280046A
(en)
|
1991-02-22 |
1994-01-18 |
The University Of Colorado Foundation, Inc. |
Method of treating type I diabetes
|
|
WO1992017467A1
(en)
|
1991-04-06 |
1992-10-15 |
Dr Lo. Zambeletti S.P.A. |
Substituted azacyclic compounds, process for their preparation and their use as analgesics
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
GB9112859D0
(en)
|
1991-06-14 |
1991-07-31 |
Ici Plc |
Peptide process
|
|
IT1250692B
(it)
|
1991-07-23 |
1995-04-21 |
|
Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
|
|
TW225528B
(https=)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
|
DE10199033I2
(de)
|
1992-04-22 |
2003-01-09 |
Ligand Parmaceuticals Inc |
Retinoid-x Rezeptor selektive Verbindungen
|
|
DE4222910A1
(de)
|
1992-07-11 |
1994-01-13 |
Asta Medica Ag |
Neue Phospholipidderivate
|
|
BR9207175A
(pt)
|
1992-10-28 |
1995-12-12 |
Genentech Inc |
Composição contendo antagonista de fator de crescimento de célula endotelial vascular sequência aminoácida de anticorpo monoclonal polipeptídeo e método de tratamento de tumor em mamífero
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
US5466861A
(en)
|
1992-11-25 |
1995-11-14 |
Sri International |
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
ES2141916T3
(es)
|
1993-11-30 |
2000-04-01 |
Searle & Co |
Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion.
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5476932A
(en)
|
1994-08-26 |
1995-12-19 |
Hoffmann-La Roche Inc. |
Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
|
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
US5633283A
(en)
|
1995-01-23 |
1997-05-27 |
Eli Lilly And Company |
Method for treating multiple sclerosis
|
|
MX9707453A
(es)
|
1995-03-30 |
1997-12-31 |
Pfizer |
Derivados de quinazolina.
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5843901A
(en)
|
1995-06-07 |
1998-12-01 |
Advanced Research & Technology Institute |
LHRH antagonist peptides
|
|
AU6267896A
(en)
|
1995-06-07 |
1996-12-30 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth oftumors
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
WO1998004689A1
(en)
|
1995-07-31 |
1998-02-05 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
|
US5675024A
(en)
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
|
FR2741881B1
(fr)
|
1995-12-01 |
1999-07-30 |
Centre Nat Rech Scient |
Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
|
|
JP3855026B2
(ja)
|
1996-01-16 |
2006-12-06 |
富士レビオ株式会社 |
アミド誘導体の製造方法
|
|
WO1997026884A1
(en)
|
1996-01-29 |
1997-07-31 |
The Regents Of The University Of California |
Method for treating sexual dysfunctions
|
|
GB9606187D0
(en)
|
1996-03-23 |
1996-05-29 |
Inst Of Food Research |
Production of vanillin
|
|
JP2000507955A
(ja)
|
1996-04-03 |
2000-06-27 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質転移酵素の阻害剤
|
|
AU714477B2
(en)
|
1996-04-19 |
2000-01-06 |
Regents Of The University Of California, The |
Treatment of mood/affective disorders by glutamatergic upmodulators
|
|
IL118657A0
(en)
|
1996-06-14 |
1996-10-16 |
Arad Dorit |
Inhibitors for picornavirus proteases
|
|
JP2000511558A
(ja)
|
1996-06-21 |
2000-09-05 |
アラーガン・セイルズ・インコーポレイテッド |
レチノイドおよび／またはレチノイド拮抗剤様生物学的活性を有する置換テトラヒドロナフタレンおよびジヒドロナフタレン誘導体
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
EP0827742A1
(en)
|
1996-09-04 |
1998-03-11 |
Vrije Universiteit Brussel |
Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
|
|
ES2301194T3
(es)
|
1997-02-05 |
2008-06-16 |
Warner-Lambert Company Llc |
Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
|
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
|
JP2001514631A
(ja)
|
1997-03-07 |
2001-09-11 |
ノボ ノルディスク アクティーゼルスカブ |
４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用
|
|
UY24949A1
(es)
|
1997-04-08 |
2001-04-30 |
Smithkline Beecham Corp |
Compuestos calcilíticos
|
|
US6159979A
(en)
|
1997-04-18 |
2000-12-12 |
Smithkline Beecham P.L.C. |
Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6329368B1
(en)
|
1997-05-09 |
2001-12-11 |
The Regents Of The University Of California |
Endocrine modulation with positive modulators of AMPA type glutamate receptors
|
|
GB9719426D0
(en)
|
1997-09-13 |
1997-11-12 |
Johnson Matthey Plc |
Novel process
|
|
ATE317226T1
(de)
|
1997-10-27 |
2006-02-15 |
Cortex Pharma Inc |
Behandlung der schizophrenie mit ampakinen und neuroleptika
|
|
AU1804299A
(en)
|
1997-12-08 |
1999-06-28 |
Glycomed Incorporated |
Sialyl lewis x and sialyl lewis a glycomimetics
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
|
EP1165492A1
(en)
|
1999-03-30 |
2002-01-02 |
Pharmacor Inc. |
Hydroxyphenyl derivatives with hiv integrase inhibitory properties
|
|
PL215901B1
(pl)
|
1999-04-15 |
2014-02-28 |
Bristol Myers Squibb Co |
Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
|
|
US6166244A
(en)
|
1999-05-07 |
2000-12-26 |
Allergan Sales, Inc. |
Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
ATE327224T1
(de)
|
1999-10-27 |
2006-06-15 |
Cytokinetics Inc |
Chinazolinone benutzende verfahren und zusammenstellungen
|
|
CZ301689B6
(cs)
|
1999-11-05 |
2010-05-26 |
Astrazeneca Ab |
Derivát chinazolinu a farmaceutický prostredek, který ho obsahuje
|
|
DE19955283A1
(de)
|
1999-11-17 |
2001-05-23 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur enantioselektiven Gewinnung von Aminosäuren und Aminosäurederivaten unter Verwendung von Racemisierungskatalysatoren
|
|
WO2001036351A2
(en)
|
1999-11-19 |
2001-05-25 |
Corvas International, Inc. |
Plasminogen activator inhibitor antagonists related applications
|
|
MY125768A
(en)
|
1999-12-15 |
2006-08-30 |
Bristol Myers Squibb Co |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
AU2001243158A1
(en)
|
2000-02-18 |
2001-08-27 |
Merck And Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
EP1261341A2
(en)
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
DE60115227T2
(de)
*
|
2000-05-11 |
2006-08-24 |
Bristol-Myers Squibb Co. |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
|
US7229986B2
(en)
*
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
|
DE10024939A1
(de)
*
|
2000-05-19 |
2001-11-29 |
Bayer Ag |
Neue Diphenylmethanderivate für Arzneimittel
|
|
CA2308994A1
(en)
*
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
|
IL136458A0
(en)
|
2000-05-30 |
2001-06-14 |
Peptor Ltd |
Protein kinase inhibitors
|
|
ATE394102T1
(de)
|
2000-06-28 |
2008-05-15 |
Astrazeneca Ab |
Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
|
|
PL204958B1
(pl)
|
2000-06-30 |
2010-02-26 |
Glaxo Group Ltd |
Ditosylany związków chinazolinowych, środek farmaceutyczny i zastosowanie tych związków
|
|
FR2812876B1
(fr)
*
|
2000-08-08 |
2002-09-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
ES2349762T3
(es)
|
2000-08-10 |
2011-01-11 |
Pfizer Italia S.R.L. |
Biciclo-pirazoles activos como inhibidores de quinasas, procedimientos para su preparación y composiciones farmacéuticas que los comprenden.
|
|
KR20030059115A
(ko)
|
2000-08-25 |
2003-07-07 |
워너-램버트 캄파니 엘엘씨 |
Ｎ-아릴-안트라닐산 및 그의 유도체의 제조 방법
|
|
CZ304344B6
(cs)
|
2000-09-11 |
2014-03-19 |
Novartis Vaccines & Diagnostics, Inc. |
Chinolinonový derivát a jeho použití a farmaceutický prostředek s obsahem tohoto derivátu
|
|
AU2002217866A1
(en)
|
2000-11-06 |
2002-05-15 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Geldanamycin derivatives useful for the treatment of cancer
|
|
US6455559B1
(en)
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
KR20090090406A
(ko)
*
|
2000-12-18 |
2009-08-25 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
염증성 사이토카인 생산 유리 억제제
|
|
NZ526472A
(en)
|
2000-12-21 |
2004-04-30 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors
|
|
DE60120494T2
(de)
|
2000-12-22 |
2006-12-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
|
|
AU2002252179A1
(en)
|
2001-03-01 |
2002-09-19 |
Conforma Therapeutics Corp. |
Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
|
|
KR100874791B1
(ko)
|
2001-05-29 |
2008-12-18 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
Ｃｄｋ-억제 피리미딘, 그의 제조방법 및 약제로서의 용도
|
|
WO2003013430A2
(en)
|
2001-08-06 |
2003-02-20 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
EP1435939B1
(en)
|
2001-09-24 |
2008-02-27 |
Conforma Therapeutic Corporation |
Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
|
|
AU2002366362A1
(en)
|
2001-12-18 |
2003-06-30 |
Bayer Aktiengesellschaft |
2-substituted pyrrolo(2.1-a)isoquinolines against cancer
|
|
CN1620294A
(zh)
|
2001-12-20 |
2005-05-25 |
Osi药物公司 |
嘧啶a2b选择性拮抗剂化合物,它们的合成及用途
|
|
EP1456180B1
(en)
|
2001-12-21 |
2007-10-03 |
Vernalis (Cambridge) Limited |
3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
|
|
SE0104462D0
(sv)
|
2001-12-29 |
2001-12-29 |
Carlbiotech Ltd As |
Peptide purifcation (Peptidrening)
|
|
WO2003061385A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents
|
|
WO2003077902A1
(en)
|
2002-02-19 |
2003-09-25 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
JP2005537223A
(ja)
|
2002-04-05 |
2005-12-08 |
ニトロメッド，インク． |
酸化窒素供与体、組成物および使用法
|
|
EP1501831A1
(en)
|
2002-04-26 |
2005-02-02 |
Warner-Lambert Company Llc |
Inhibitors of checkpoint kinases (wee1 and chk1)
|
|
WO2003103648A1
(ja)
*
|
2002-06-05 |
2003-12-18 |
株式会社医薬分子設計研究所 |
糖尿病治療薬
|
|
EP1512396A4
(en)
|
2002-06-05 |
2008-12-31 |
Inst Med Molecular Design Inc |
HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT
|
|
WO2003103658A1
(ja)
*
|
2002-06-05 |
2003-12-18 |
株式会社医薬分子設計研究所 |
免疫関連プロテインキナーゼ阻害剤
|
|
CA2488367A1
(en)
|
2002-06-06 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Antiallergic agents
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
|
SE0202133D0
(sv)
|
2002-07-08 |
2002-07-08 |
Astrazeneca Ab |
Novel compounds
|
|
CA2393720C
(en)
|
2002-07-12 |
2010-09-14 |
Eli Lilly And Company |
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
|
|
DE60326473D1
(en)
|
2002-07-16 |
2009-04-16 |
Amura Therapeutics Ltd |
Pyrrolderivate als hemmstoffe von cystein proteasen
|
|
US6800655B2
(en)
|
2002-08-20 |
2004-10-05 |
Sri International |
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
|
|
WO2004035571A1
(en)
|
2002-10-15 |
2004-04-29 |
Rigel Pharmaceuticals, Inc. |
Substituted indoles and their use as hcv inhibitors
|
|
AU2003302589A1
(en)
|
2002-12-02 |
2004-06-23 |
Kyukyu Pharmaceutical Co., Ltd. |
Method for producing orally administrable edible agent of laminate film form and pressure bonding apparatus of the agent.
|
|
TWI228885B
(en)
*
|
2003-01-23 |
2005-03-01 |
Mediatek Inc |
Method for controlling a mobile communication device to enter a power-saving mode and to recover timing after the mobile communication device leaves the power-saving mode
|
|
EA009919B1
(ru)
|
2003-02-11 |
2008-04-28 |
Вернэлис (Кембридж) Лимитед |
Соединения изоксазола
|
|
RU2324493C2
(ru)
*
|
2003-02-20 |
2008-05-20 |
Юниверсити Оф Коннектикут Хелт Сентер |
Способ применения композиций, содержащих белки теплового шока или альфа-2-макроглобулин, для лечения рака и инфекционных болезней
|
|
JP2006518368A
(ja)
|
2003-02-21 |
2006-08-10 |
ファイザー・インク |
プロテインキナーゼ阻害剤としてのｎ−ヘテロシクリル置換アミノチアゾール誘導体
|
|
BR0318145A
(pt)
|
2003-02-26 |
2006-02-21 |
Boehringer Ingelheim Pharma |
dihidropteridinonas, processos para a sua preparação e sua aplicação como medicamento
|
|
US7038038B2
(en)
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
|
BRPI0409230A
(pt)
|
2003-04-03 |
2006-03-28 |
Pfizer |
formas de dosagem compreendendo ag013736
|
|
CA2523677A1
(en)
|
2003-04-30 |
2004-11-11 |
Novartis Ag |
Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
AU2004251949B2
(en)
|
2003-06-27 |
2009-05-07 |
Kyowa Hakko Kirin Co., Ltd. |
Hsp90 family protein inhibitors
|
|
TWI312345B
(en)
*
|
2003-06-30 |
2009-07-21 |
Mitsubishi Tanabe Pharma Corp |
Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives
|
|
TWI372050B
(en)
*
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
RU2006104697A
(ru)
*
|
2003-07-16 |
2006-06-27 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. (Jp) |
Лекарственное средство для лечения пигментации кожи
|
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
|
DK1658263T3
(da)
|
2003-07-24 |
2010-09-27 |
Leo Pharma As |
Aminobenzophenonforbindelser
|
|
CN1856490A
(zh)
|
2003-07-28 |
2006-11-01 |
詹森药业有限公司 |
苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
|
|
DE10335584B4
(de)
|
2003-07-31 |
2006-06-29 |
Philipps-Universität Marburg |
Verfahren zur Herstellung zyklischer Moleküle
|
|
DE10335726A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Bayer Cropscience Gmbh |
Verwendung von Hydroxyaromaten als Safener
|
|
WO2005016889A1
(en)
|
2003-08-08 |
2005-02-24 |
Virginia Commonwealth University |
Compounds having antiestrogenic and tissue selective estrogenic properties
|
|
EP1670804A2
(en)
|
2003-09-10 |
2006-06-21 |
GPC Biotech AG |
Heterobicyclic compounds as pharmaceutically active agents
|
|
AU2004282179B2
(en)
|
2003-10-14 |
2011-05-19 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein kinase inhibitors
|
|
HRP20130098T1
(hr)
|
2003-10-14 |
2013-02-28 |
F. Hoffmann - La Roche Ag |
MAKROCIKLIÄŚKE KARBOKSILNE KISELINE I ACILSULFONAMIDNI SPOJEVI KAO INHIBITORI REPLIKACIJE HCV-a
|
|
CN102225926A
(zh)
|
2003-11-07 |
2011-10-26 |
诺华疫苗和诊断公司 |
具有改进药物特性的喹啉酮类化合物的药学上可接受的盐
|
|
JP2007513082A
(ja)
|
2003-11-10 |
2007-05-24 |
シエーリング アクチエンゲゼルシャフト |
Ｃｃｒ−５アンタゴニストとして有用なベンジルエーテルアミン化合物
|
|
RU2362562C2
(ru)
|
2003-11-18 |
2009-07-27 |
Новартис Аг |
Ингибиторы мутантной формы киназы kit
|
|
BRPI0418147A
(pt)
|
2003-12-23 |
2007-04-17 |
Infinity Pharmaceuticals Inc |
análogos de ansamicinas contendo benzoquinona e seus métodos de uso
|
|
JPWO2005063222A1
(ja)
|
2003-12-26 |
2007-07-19 |
協和醗酵工業株式会社 |
Ｈｓｐ９０ファミリー蛋白質阻害剤
|
|
US7652146B2
(en)
|
2004-02-06 |
2010-01-26 |
Bristol-Myers Squibb Company |
Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
|
|
TWI338004B
(en)
|
2004-02-06 |
2011-03-01 |
Bristol Myers Squibb Co |
Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
|
|
US20050256097A1
(en)
|
2004-05-11 |
2005-11-17 |
Kosan Biosciences, Inc. |
Pharmaceutical solution formulations containing 17-AAG
|
|
ES2540987T3
(es)
|
2004-05-14 |
2015-07-15 |
Millennium Pharmaceuticals, Inc. |
Métodos para preparar inhibidores de la aurora cinasa
|
|
US7351709B2
(en)
*
|
2004-06-09 |
2008-04-01 |
Wyeth |
Estrogen receptor ligands
|
|
US20060014949A1
(en)
|
2004-07-13 |
2006-01-19 |
Supergen Inc. |
Compositions and formulations of decitabine polymorphs and methods of use thereof
|
|
EP1781654A1
(en)
|
2004-07-27 |
2007-05-09 |
SGX Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US7728134B2
(en)
|
2004-08-14 |
2010-06-01 |
Boehringer Ingelheim International Gmbh |
Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
|
|
CA2577752A1
(en)
|
2004-08-20 |
2006-03-02 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
|
|
US20060069060A1
(en)
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
|
US20060067953A1
(en)
|
2004-09-29 |
2006-03-30 |
Conforma Therapeutics Corporation |
Oral pharmaceutical formulations and methods for producing and using same
|
|
DE102004049078A1
(de)
|
2004-10-08 |
2006-04-13 |
Merck Patent Gmbh |
Phenylpyrazole
|
|
US7208630B2
(en)
|
2004-10-27 |
2007-04-24 |
University Of Kansas |
Heat shock protein 90 inhibitors
|
|
AU2005300311A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Methods for preparing indazole compounds
|
|
WO2006050373A2
(en)
|
2004-11-02 |
2006-05-11 |
The Regents Of The University Of California |
Methods and compositions for modulating apoptosis
|
|
CN101094836A
(zh)
|
2004-11-02 |
2007-12-26 |
辉瑞大药厂 |
制备吲唑化合物的方法
|
|
JPWO2006051808A1
(ja)
*
|
2004-11-09 |
2008-05-29 |
協和醗酵工業株式会社 |
Ｈｓｐ９０ファミリー蛋白質阻害剤
|
|
WO2006055760A1
(en)
|
2004-11-18 |
2006-05-26 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
EP1833819A1
(en)
|
2004-12-30 |
2007-09-19 |
Astex Therapeutics Limited |
Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
DE602006010665D1
(en)
|
2005-02-07 |
2010-01-07 |
Hoffmann La Roche |
Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
|
|
US20060183902A1
(en)
*
|
2005-02-15 |
2006-08-17 |
Baxter Ellen W |
Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms
|
|
CN101123954B
(zh)
|
2005-02-21 |
2011-07-13 |
协和发酵麒麟株式会社 |
抗肿瘤剂
|
|
KR101411167B1
(ko)
*
|
2005-04-13 |
2014-06-23 |
아스텍스 테라퓨틱스 리미티드 |
하이드록시벤즈아미드 유도체 및 ｈｓｐ90 억제제로서의이의 용도
|
|
JP2008540395A
(ja)
*
|
2005-05-03 |
2008-11-20 |
ファイザー・インク |
アミドレソルシノール化合物
|
|
DK2444079T3
(en)
|
2005-05-17 |
2017-01-30 |
Sarcode Bioscience Inc |
Compositions and Methods for the Treatment of Eye Diseases
|
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
|
US7425633B2
(en)
*
|
2005-08-26 |
2008-09-16 |
National Health Research Institutes |
Pyrrolidine compounds
|
|
EP1968579A1
(en)
|
2005-12-30 |
2008-09-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
US7785275B2
(en)
*
|
2006-01-31 |
2010-08-31 |
Cook Incorporated |
Wire guide having distal coupling tip
|
|
US7754725B2
(en)
*
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
|
JP5518478B2
(ja)
*
|
2006-10-12 |
2014-06-11 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
GB0620259D0
(en)
*
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
JP5410285B2
(ja)
|
2006-10-12 |
2014-02-05 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
JP5528807B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
EP2073802A1
(en)
*
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008053319A1
(en)
|
2006-10-30 |
2008-05-08 |
Pfizer Products Inc. |
Amide resorcinol compounds
|
|
BRPI0906255A2
(pt)
*
|
2008-06-11 |
2015-09-22 |
Morinaga Milk Industry Co Ltd |
método para produzir leite fermentado
|